Cross Country Healthcare, Inc. (CCRN) has a negative trailing P/E of -3.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 89.7 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -30.83%, forward earnings yield 1.11%. PEG 1.20.
Criteria proven by this page:
Overall SharesGrow Score: 41/100 with 1/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 63.0 | 0.80 | 3.32 | 0.60 | - |
| 2017 | 11.9 | 0.04 | 1.88 | 0.52 | - |
| 2018 | -15.3 | 0.11 | 1.19 | 0.32 | - |
| 2019 | -7.2 | -0.03 | 2.56 | 0.51 | - |
| 2020 | -24.7 | 0.32 | 2.07 | 0.38 | - |
| 2021 | 7.7 | -0.01 | 3.42 | 0.61 | - |
| 2022 | 5.3 | 0.13 | 2.15 | 0.35 | - |
| 2023 | 11.0 | -0.18 | 1.68 | 0.39 | - |
| 2024 | -41.6 | 0.34 | 1.45 | 0.45 | - |
| 2025 | -2.8 | 0.00 | 0.81 | 0.25 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.15 | $833.54M | $7.97M | 1% |
| 2017 | $1.01 | $865.05M | $37.51M | 4.3% |
| 2018 | $-0.48 | $816.48M | $-16.95M | -2.1% |
| 2019 | $-1.56 | $822.22M | $-55.94M | -6.8% |
| 2020 | $-0.34 | $836.42M | $-12.14M | -1.5% |
| 2021 | $3.53 | $1.68B | $132M | 7.9% |
| 2022 | $5.02 | $2.81B | $188.46M | 6.7% |
| 2023 | $2.05 | $2.02B | $72.63M | 3.6% |
| 2024 | $-0.44 | $1.34B | $-14.56M | -1.1% |
| 2025 | $-2.93 | $1.05B | $-94.85M | -9% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $0.11 | $0.03 – $0.19 | $976.58M | $965.07M – $985.98M | 6 |
| 2027 | $0.27 | $0.21 – $0.35 | $1.03B | $1.01B – $1.04B | 6 |
| 2028 | $0.37 | $0.36 – $0.38 | $1.08B | $1.06B – $1.09B | 1 |
| 2029 | $0.59 | $0.58 – $0.60 | $1.13B | $1.11B – $1.15B | 1 |
| 2030 | $1.02 | $1.00 – $1.04 | $1.19B | $1.17B – $1.21B | 1 |
